(Q43783134)

26 November 2017

title

SPIRIT 2013: new guidance for content of clinical trial protocols (English)

1 reference

26 November 2017

5

1 reference

26 November 2017

3

Douglas G Altman

0 references

Kay Dickersin

series ordinal

4

object named as

Kay Dickersin

1 reference

26 November 2017

An-Wen Chan

1

1 reference

26 November 2017

Jennifer M Tetzlaff

series ordinal

2

1 reference

26 November 2017

language of work or name

English

0 references

publication date

8 January 2013

1 reference

26 November 2017

1 reference

26 November 2017

volume

381

1 reference

26 November 2017

issue

9861

1 reference

26 November 2017

page(s)

91-92

1 reference

SPIRIT 2013 statement: defining standard protocol items for clinical trials

26 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2962160-6

7 January 2021

Empirical evidence for selective reporting of outcomes in randomized trials: comparison of protocols to published articles

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2962160-6

7 January 2021

Frequency and reasons for outcome reporting bias in clinical trials: interviews with trialists

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2962160-6

7 January 2021

Adverse event reporting in publications compared with sponsor database for cancer clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2962160-6

7 January 2021

Access to data in industry-sponsored trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2962160-6

7 January 2021

Guidelines for randomized clinical trial protocol content: a systematic review

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2962160-6

7 January 2021

The activity of French research ethics committees and characteristics of biomedical research protocols involving humans: a retrospective cohort study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2962160-6

7 January 2021

Bridging the gap: improving clinical development and the regulatory pathways for health products for neglected diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2962160-6

7 January 2021

Developing a guideline for clinical trial protocol content: Delphi consensus survey

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2962160-6

7 January 2021

SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2962160-6

7 January 2021

Does use of the CONSORT Statement impact the completeness of reporting of randomised controlled trials published in medical journals? A Cochrane review

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2962160-6

7 January 2021

10.1016/S0140-6736(12)62160-6

Identifiers

DOI

1 reference

26 November 2017

1 reference